S
Sonoma Pharmaceuticals Inc (SNOA)
Official siteHEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ
$0.88
-0.21 (-19.25%)
Market Cap: $5.52M
Last updated: Nov 17, 2026 at 11:01 AM ET
Sonoma Pharmaceuticals Inc (SNOA) Valuation Multiples
Sonoma Pharmaceuticals (SNOA) trades at 0.2x sales and 0.7x book value. Its P/S of 0.2x is below its 5-year median of 0.3x. Its forward P/E is 46.1x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 46.1x |
| Price to sales | 0.2x |
| Price to book | 0.7x |
| PEG | N/A |
| FCF yield | -64.5% |
Historical Medians
Against its 10-year medians, its P/B is 46.2% below 1.3x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.2x | 0.3x | N/A |
| P/B | 0.7x | 1.2x | 1.3x |
Valuation History
Over the 5 of the 10 year ends shown that have a P/S, its P/S ranged from 0.2x in 2024 to 17.1x in 2021.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $3.64 | N/A | 0.3x | 1.8x |
| 2024 | $2.69 | N/A | 0.2x | 0.8x |
| 2023 | $3.61 | N/A | N/A | 0.3x |
| 2022 | $22.40 | N/A | 6.0x | 18.7x |
| 2021 | $91.20 | N/A | 17.1x | 25.1x |
| 2020 | $145.20 | N/A | N/A | 24.2x |
| 2019 | $87.20 | N/A | 0.4x | 0.6x |
| 2018 | $128.26 | N/A | N/A | 0.5x |
| 2017 | $981.10 | N/A | N/A | 1.7x |
| 2016 | $907.29 | 1.6x | N/A | 0.9x |
Frequently Asked Questions About SNOA
What is SNOA's forward P/E ratio?
Sonoma Pharmaceuticals has a forward P/E ratio of 46.1x.
What is SNOA's price to sales ratio?
Sonoma Pharmaceuticals has a price to sales ratio of 0.2x.
SNOA pages: Overview, Earnings, Financials, Valuation, Competitors